Company / Current Assets per Share
Xenon Pharmaceuticals Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$7.07
FY2025
5-year range
$7.07 / $12.81
FY2021-FY2025
Trend
-13.3%
vs FY2024
Sector context
#105 of 210
Health Care
What the data says
At $7.07, Xenon Pharmaceuticals Inc.'s current assets per share ranks #105 of 210 in the Health Care sector. Current Assets per Share has declined for 4 consecutive years, from $12.81 in FY2021 to $7.07 in FY2025.
Based on SEC 10-K filings.
7.07 in FY2025 with a 5-year CAGR of +6.1%.
Declined from $9.64 to $7.07 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -10.6%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Sector benchmark
#105 of 210 in Health CareTop 50% of 210This company $7.07 Sector average $170.65
▼
-95.9% below sector average
Key checks
Key Insights
- Xenon Pharmaceuticals Inc.'s current assets per share has declined for 4 consecutive years.
- In FY2025, current assets per share decreased 13.3% year-over-year.
- Ranks #105 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.07 | -13.3% |
| FY2024 | $8.16 | -15.4% |
| FY2023 | $9.64 | -2.8% |
| FY2022 | $9.92 | -22.6% |
| FY2021 | $12.81 | +143.5% |
| FY2020 | $5.26 | -5.8% |
| FY2019 | $5.58 | -17.2% |
| FY2018 | $6.74 | +169.7% |
| FY2017 | $2.50 | -45.2% |
| FY2016 | $4.57 | +6.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026